Shaoxing BSM Chemical Co., Ltd.
SZSE:300796.SZ
13.49 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,328.261 | 699.191 | 768.072 | 530.016 | 404.543 | 494.092 | 465.222 | 434.177 | 338.012 | 276.923 |
| Cost of Revenue
| 1,151.435 | 453.095 | 474.784 | 374.314 | 298.324 | 353.359 | 305.365 | 276.588 | 230.772 | 193.892 |
| Gross Profit
| 176.826 | 246.095 | 293.288 | 155.702 | 106.22 | 140.733 | 159.857 | 157.588 | 107.24 | 83.031 |
| Gross Profit Ratio
| 0.133 | 0.352 | 0.382 | 0.294 | 0.263 | 0.285 | 0.344 | 0.363 | 0.317 | 0.3 |
| Reseach & Development Expenses
| 45.52 | 40.033 | 37.579 | 32.595 | 22.815 | 29.475 | 28.537 | 51.74 | 37.847 | 15.042 |
| General & Administrative Expenses
| 36.942 | 33.536 | 17.119 | 13.665 | 14.768 | 13.758 | 0.187 | -23.008 | -14.105 | 12.399 |
| Selling & Marketing Expenses
| 39.059 | 14.223 | 12.411 | 11.055 | 9.413 | 17.666 | 15.33 | 15.273 | 13.183 | 11.459 |
| SG&A
| 76.002 | 47.76 | 29.529 | 24.72 | 24.181 | 31.425 | 15.516 | -7.735 | -0.922 | 23.858 |
| Other Expenses
| 111.874 | 45.873 | -7.634 | -3.667 | -5.52 | 11.406 | -1.752 | 4.502 | 9.812 | 1.107 |
| Operating Expenses
| 233.396 | 133.666 | 96.269 | 82.178 | 56.051 | 74.141 | 69.478 | 62.247 | 53.974 | 48.264 |
| Operating Income
| -56.569 | 112.43 | 190.728 | 68.455 | 48.312 | 62.158 | 91.792 | 88.955 | 45.428 | 31.246 |
| Operating Income Ratio
| -0.043 | 0.161 | 0.248 | 0.129 | 0.119 | 0.126 | 0.197 | 0.205 | 0.134 | 0.113 |
| Total Other Income Expenses Net
| -1.395 | -1.69 | -7.634 | -3.667 | -5.52 | 11.406 | 0.532 | -0.04 | 1.829 | 1.107 |
| Income Before Tax
| -57.964 | 110.74 | 183.094 | 64.788 | 42.792 | 73.564 | 92.325 | 88.915 | 47.256 | 32.353 |
| Income Before Tax Ratio
| -0.044 | 0.158 | 0.238 | 0.122 | 0.106 | 0.149 | 0.198 | 0.205 | 0.14 | 0.117 |
| Income Tax Expense
| -21.054 | 18.548 | 25.917 | 7.517 | 4.596 | 8.472 | 10.942 | 11.94 | 6.729 | 5.12 |
| Net Income
| -32.865 | 88.411 | 152.885 | 56.394 | 38.412 | 63.653 | 77.952 | 73.171 | 36.91 | 24.687 |
| Net Income Ratio
| -0.025 | 0.126 | 0.199 | 0.106 | 0.095 | 0.129 | 0.168 | 0.169 | 0.109 | 0.089 |
| EPS
| -0.09 | 0.24 | 0.44 | 0.18 | 0.13 | 0.21 | 0.34 | 0.33 | 0.19 | 0.15 |
| EPS Diluted
| -0.09 | 0.24 | 0.44 | 0.18 | 0.13 | 0.21 | 0.34 | 0.33 | 0.19 | 0.15 |
| EBITDA
| 66.817 | 170.171 | 240.743 | 113.122 | 80.689 | 90.08 | 115.862 | 94.784 | 58.379 | 36.244 |
| EBITDA Ratio
| 0.05 | 0.243 | 0.313 | 0.213 | 0.199 | 0.182 | 0.249 | 0.218 | 0.173 | 0.131 |